Eiken Chemical Co Ltd 4549
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥2,420.00
- Day Range
- ¥2,355.00–2,439.00
- 52-Week Range
- ¥1,334.00–2,468.00
- Bid/Ask
- ¥2,378.00 / ¥2,398.00
- Market Cap
- ¥82.86 Bil
- Volume/Avg
- 138,200 / 88,335
Key Statistics
- Price/Earnings (Normalized)
- 33.25
- Price/Sales
- 2.20
- Dividend Yield (Trailing)
- 2.17%
- Dividend Yield (Forward)
- 2.17%
- Total Yield
- 7.85%
Company Profile
Eiken Chemical Co Ltd is a Japan-based company. It manufactures and sells clinical diagnostics and equipment. The company is engaged in processing, manufacture, purchase and sale of test agents, property and casualty insurance agency business. It as a general manufacturer of clinical diagnostics offers a wide range of in vitro diagnostic aids for all fields of medicine. Its major products include the Fecal immunochemical test, Molecular Genetics (LAMP), Microbiology, among many others.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,053
- Website
- http://www.eiken.co.jp
Comparables
Valuation
Metric
|
4549
|
197A
|
603658
|
---|---|---|---|
Price/Earnings (Normalized) | 33.25 | — | 19.87 |
Price/Book Value | 1.80 | — | 3.10 |
Price/Sales | 2.20 | — | 5.53 |
Price/Cash Flow | 20.36 | — | 13.96 |
Price/Earnings
4549
197A
603658
Financial Strength
Metric
|
4549
|
197A
|
603658
|
---|---|---|---|
Quick Ratio | 2.57 | 1.04 | 0.99 |
Current Ratio | 3.33 | 1.31 | 2.71 |
Interest Coverage | 206.59 | 214.26 | 57.12 |
Quick Ratio
4549
197A
603658
Profitability
Metric
|
4549
|
197A
|
603658
|
---|---|---|---|
Return on Assets (Normalized) | 5.49% | 16.73% | 11.37% |
Return on Equity (Normalized) | 7.27% | 40.76% | 15.28% |
Return on Invested Capital (Normalized) | 6.79% | 23.80% | 14.14% |
Return on Assets
4549
197A
603658
Medical Devices Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
Abbott Laboratories
ABT
| Wnpbtgxbl | Xlzyv | $195.6 Bil | |||
Stryker Corp
SYK
| Ncmwgghcx | Gdl | $137.3 Bil | |||
Boston Scientific Corp
BSX
| Tzpcgrb | Fsbkg | $122.7 Bil | |||
Medtronic PLC
MDT
| Ykgfpynd | Sqfjpy | $114.6 Bil | |||
Edwards Lifesciences Corp
EW
| Mjdngnzwwm | Zchkk | $40.1 Bil | |||
Koninklijke Philips NV ADR
PHG
| Whkn | Fcjzm | $30.7 Bil | |||
DexCom Inc
DXCM
| Qhmgpdvc | Tshsp | $27.0 Bil | |||
Steris PLC
STE
| Xkjddrmng | Mwtyw | $23.6 Bil | |||
Zimmer Biomet Holdings Inc
ZBH
| Slbfkbnvq | Rpmt | $22.0 Bil | |||
Insulet Corp
PODD
| Kqlqdlhxj | Ppdxyt | $16.3 Bil |